Sarcoidosis and Its Dermatological Manifestations: A Narrative Review

被引:11
作者
Koneti, Jancy [1 ]
Cherukuri, Swathi Priya [2 ]
Gadde, Sai [1 ]
Kalluru, Revanth [1 ]
Chikatimalla, Rahul [1 ]
Dasaradhan, Thejaswi [2 ]
机构
[1] Kamineni Inst Med Sci, Res, Narketpally, India
[2] Narayana Med Coll, Res, Nellore, India
关键词
subcutaneous nodules; erythema nodosum; lupus pernio; cutaneous sarcoidosis; sarcoidosis; CHRONIC CUTANEOUS SARCOIDOSIS; LUPUS PERNIO; SUBCUTANEOUS SARCOIDOSIS; PULMONARY SARCOIDOSIS; ERYTHEMA-NODOSUM; SKIN; METHOTREXATE; INFLIXIMAB; LESIONS; SUBSET;
D O I
10.7759/cureus.28053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sarcoidosis is an enigma diagnosed by ruling out other etiologies of granulomatous inflammation. The multisystem manifestations of sarcoidosis and the clinical polymorphism pose a diagnostic challenge to all physicians. The skin is the most commonly affected organ after the lungs in sarcoidosis. Dermatological manifestations can appear before, during, or after systemic involvement, and the type of skin lesion can have prognostic significance. Also, a biopsy of skin lesions is less invasive and more accessible to perform than a biopsy of visceral organs. Thus, in certain ways, cutaneous manifestations can aid in the diagnosis and prognosis of systemic disease. This article has focused on the frequently encountered skin lesions of sarcoidosis along with their prevalence, clinical features, and management.
引用
收藏
页数:8
相关论文
共 68 条
  • [1] Subcutaneous sarcoidosis: Is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease?
    Ahmed, I
    Harshad, SR
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (01) : 55 - 60
  • [2] [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736
  • [3] Development of sarcoidosis in cosmetic tattoos
    Antonovich, DD
    Callen, JP
    [J]. ARCHIVES OF DERMATOLOGY, 2005, 141 (07) : 869 - 872
  • [4] Scar sarcoidosis: 11 patients with variable clinical features and invariable pulmonary involvement
    Atci, T.
    Baykal, C.
    Bingol, Z. Kaya
    Ekinci, A. Polat
    Kilicaslan, Z.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (07) : 826 - 828
  • [5] Bachelez H, 2001, ARCH DERMATOL, V137, P69
  • [6] Baughman RP, 2015, SARCOIDOSIS VASC DIF, V32, P289
  • [7] Clinical characteristics of patients in a case control study of sarcoidosis
    Baughman, RP
    Teirstein, AS
    Judson, MA
    Rossman, MD
    Yeager, H
    Bresnitz, EA
    DePalo, L
    Hunninghake, G
    Iannuzzi, MC
    Johns, CJ
    McLennan, G
    Moller, DR
    Newman, LS
    Rabin, DL
    Rose, C
    Rybicki, B
    Weinberger, SE
    Terrin, ML
    Knatterud, GL
    Cherniak, R
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (10) : 1885 - 1889
  • [8] A clinical approach to the use of methotrexate for sarcoidosis
    Baughman, RP
    Lower, EE
    [J]. THORAX, 1999, 54 (08) : 742 - 746
  • [9] Cutaneous Sarcoidosis
    Caplan, Avrom
    Rosenbach, Misha
    Imadojemu, Sotonye
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (05) : 689 - 699
  • [10] TREATMENT OF CUTANEOUS AND PULMONARY SARCOIDOSIS WITH THALIDOMIDE
    CARLESIMO, M
    GIUSTINI, S
    ROSSI, A
    BONACCORSI, P
    CALVIERI, S
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (05) : 866 - 869